Both in Pharmaceuticals
Prestige Consumer Healthcare vs Xencor
Over the past year PBH returned −19.0% and XNCR returned +102.7%; their daily moves had a correlation of -0.01.
PBH −19.0% XNCR +102.7%Growth of $1, one year, split-adjusted
| Metric | PBH | XNCR |
|---|---|---|
| Price | $49.06 | $29.82 |
| Market cap | $2.32B | $2.22B |
| Today | +0.64% | +2.09% |
| 1 month | +9.6% | +20.4% |
| 6 months | −10.9% | +135.0% |
| Year to date | −20.5% | +94.8% |
| 1 year | −19.2% | +103.3% |
| Revenue growth (YoY) | +6.5% | +17.5% |
| Gross margin | 51.3% | 100.0% |
| Net margin | 11.0% | −42.4% |
| P/E (TTM) | 13.5× | — |
| Price / sales | 2.1× | 21.1× |
| Net cash | -$1.95B | $351.6M |
| Dividend yield | — | — |
| Volatility (60d) | 30.7% | 62.4% |
| Short % of float | 8.5% | 17.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).